Qilu Pharmaceutical's Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor Injection Price Reduced to RMB 1,670 per Vial
Feb 05, 2021 14:43
CST Updated
14:43
Qilu Pharmaceutical
Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer
On February 4, the Public Resource Trading Service Center of Ningxia Hui Autonomous Region issued a notice on adjusting the listed price of Qilu Pharmaceutical Co., Ltd.'s Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor Injection.
Notice: Upon the application of Qilu Pharmaceutical Co., Ltd., the online listing price of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor Injection (specification: 3.0 mg/vial; manufacturer: Qilu Pharmaceutical Co., Ltd.) is hereby reduced to RMB 1,670 per vial. The adjusted price takes effect immediately.to be implemented.
